[Rhythmic disorders due to digitalis overdose].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000367:Age Factors; D000368:Aged; D001145:Arrhythmias, Cardiac / Q000139:chemically induced* / Q000188:drug therapy; D003327:Coronary Disease / Q000188:drug therapy; D004071:Digitalis Glycosides / Q000009:adverse effects*; D004492:Edetic Acid / Q000627:therapeutic use; D004562:Electrocardiography; D005260:Female; D006331:Heart Diseases / Q000188:drug therapy; D006333:Heart Failure / Q000188:drug therapy; D006801:Humans; D008012:Lidocaine / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010672:Phenytoin / Q000627:therapeutic use; D011188:Potassium / Q000627:therapeutic use; D011342:Procainamide / Q000627:therapeutic use; D011802:Quinidine / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D004071:Digitalis Glycosides; D010672:Phenytoin; D008012:Lidocaine; D004492:Edetic Acid; D011802:Quinidine; D011342:Procainamide; D011188:Potassium
Troubles du rythme par surdosage digitalique.